TY - JOUR
T1 - Pathogen genomic surveillance status among lower resource settings in Asia
AU - On behalf of the Asia Pathogen Genomics Initiative (Asia PGI) consortium
AU - Getchell, Marya
AU - Wulandari, Suci
AU - de Alwis, Ruklanthi
AU - Agoramurthy, Shreya
AU - Khoo, Yoong Khean
AU - Mak, Tze Minn
AU - Moe, La
AU - Stona, Anne Claire
AU - Pang, Junxiong
AU - Momin, Muhd Haziq Fikry Haji Abdul
AU - Amir, Afreenish
AU - Andalucia, Lucia Rizka
AU - Azzam, Ghows
AU - Chin, Savuth
AU - Chookajorn, Thanat
AU - Arunkumar, Govindakarnavar
AU - Hung, Do Thai
AU - Ikram, Aamer
AU - Jha, Runa
AU - Karlsson, Erik A.
AU - Le Thi, Mai Quynh
AU - Mahasirimongkol, Surakameth
AU - Malavige, Gathsaurie Neelika
AU - Manning, Jessica E.
AU - Munira, Syarifah Liza
AU - Trung, Nguyen Vu
AU - Nisar, Imran
AU - Qadri, Firdausi
AU - Qamar, Farah Naz
AU - Robinson, Matthew T.
AU - Saloma, Cynthia P.
AU - Setk, Swe
AU - Shirin, Tahmina
AU - Tan, Le Van
AU - Dizon, Timothy John R.
AU - Thayan, Ravindran
AU - Thu, Hlaing Myat
AU - Tissera, Hasitha
AU - Xangsayarath, Phonepadith
AU - Zaini, Zainun
AU - Lim, John C.W.
AU - Maurer-Stroh, Sebastian
AU - Smith, Gavin J.D.
AU - Wang, Lin Fa
AU - Pronyk, Paul
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024
Y1 - 2024
N2 - Asia remains vulnerable to new and emerging infectious diseases. Understanding how to improve next generation sequencing (NGS) use in pathogen surveillance is an urgent priority for regional health security. Here we developed a pathogen genomic surveillance assessment framework to assess capacity in low-resource settings in South and Southeast Asia. Data collected between June 2022 and March 2023 from 42 institutions in 13 countries showed pathogen genomics capacity exists, but use is limited and under-resourced. All countries had NGS capacity and seven countries had strategic plans integrating pathogen genomics into wider surveillance efforts. Several pathogens were prioritized for human surveillance, but NGS application to environmental and human–animal interface surveillance was limited. Barriers to NGS implementation include reliance on external funding, supply chain challenges, trained personnel shortages and limited quality assurance mechanisms. Coordinated efforts are required to support national planning, address capacity gaps, enhance quality assurance and facilitate data sharing for decision making.
AB - Asia remains vulnerable to new and emerging infectious diseases. Understanding how to improve next generation sequencing (NGS) use in pathogen surveillance is an urgent priority for regional health security. Here we developed a pathogen genomic surveillance assessment framework to assess capacity in low-resource settings in South and Southeast Asia. Data collected between June 2022 and March 2023 from 42 institutions in 13 countries showed pathogen genomics capacity exists, but use is limited and under-resourced. All countries had NGS capacity and seven countries had strategic plans integrating pathogen genomics into wider surveillance efforts. Several pathogens were prioritized for human surveillance, but NGS application to environmental and human–animal interface surveillance was limited. Barriers to NGS implementation include reliance on external funding, supply chain challenges, trained personnel shortages and limited quality assurance mechanisms. Coordinated efforts are required to support national planning, address capacity gaps, enhance quality assurance and facilitate data sharing for decision making.
UR - http://www.scopus.com/inward/record.url?scp=85204786027&partnerID=8YFLogxK
U2 - 10.1038/s41564-024-01809-4
DO - 10.1038/s41564-024-01809-4
M3 - Article
AN - SCOPUS:85204786027
SN - 2058-5276
JO - Nature Microbiology
JF - Nature Microbiology
ER -